Evidence map›Paper›PMID 38349785›Full record

ArticleInvestigative ophthalmology & visual science2024

Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.

Martina C Herwig-Carl, Amit Sharma, Verena Tischler, Natalie Pelusi, Karin U Loeffler, Frank G Holz, Michael Zeschnigk, Solange Landreville, Claudia Auw-Haedrich, Roberta Noberini and 1 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Martina C Herwig-CarlDepartment of Ophthalmology, University Hospital Bonn, Bonn, Germany.
Amit SharmaDepartment of Ophthalmology, University Hospital Bonn, Bonn, Germany.
Verena TischlerInstitute of Pathology, University Hospital Bonn, Bonn, Germany.
Natalie PelusiInstitute of Pathology, University Hospital Bonn, Bonn, Germany.
Karin U LoefflerDepartment of Ophthalmology, University Hospital Bonn, Bonn, Germany.
Frank G HolzDepartment of Ophthalmology, University Hospital Bonn, Bonn, Germany.
Michael ZeschnigkInstitute of Human Genetics, University Hospital Essen, Essen, Germany.
Solange LandrevilleDepartment of Ophthalmology and Otolaryngology-Cervicofacial Surgery, Université Laval, Quebec City, Quebec, Canada.
Claudia Auw-HaedrichDepartment of Ophthalmology, University Hospital Freiburg, Freiburg, Germany.
Roberta NoberiniDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
Tiziana BonaldiDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
University Hospital Bonn · DEEssen University Hospital · DEEuropean Institute of Oncology · ITUniversité Laval · CAUniversity Medical Center Freiburg · DEUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Epigenetic alterations in uveal melanoma (UM) are still neither well characterized, nor understood. In this pilot study, we sought to provide a deeper insight into the possible role of epigenetic alterations in the pathogenesis of UM and their potential prognostic relevance. To this aim, we comprehensively profiled histone post-translational modifications (PTMs), which represent epigenetic features regulating chromatin accessibility and gene transcription, in UM formalin-fixed paraffin-embedded (FFPE) tissues, control tissues, UM cell lines, and healthy melanocytes. Methods: FFPE tissues of UM (n = 24), normal choroid (n = 4), human UM cell lines (n = 7), skin melanocytes (n = 6), and uveal melanocytes (n = 2) were analyzed through a quantitative liquid chromatography-mass spectrometry (LC-MS) approach. Results: Hierarchical clustering showed a clear separation with several histone PTMs that changed significantly in a tumor compared to normal samples, in both tissues and cell lines. In addition, several acetylations and H4K20me1 showed lower levels in BAP1 mutant tumors. Some of these changes were also observed when we compared GNA11 mutant tumors with GNAQ tumors. The epigenetic profiling of cell lines revealed that the UM cell lines MP65 and UPMM1 have a histone PTM pattern closer to the primary tissues than the other cell lines analyzed. Conclusions: Our results suggest the existence of different histone PTM patterns that may be important for diagnosis and prognosis in UM. However, further analyses are needed to confirm these findings in a larger cohort. The epigenetic characterization of a panel of UM cell lines suggested which cellular models are more suitable for epigenetic investigations.

Indexed as

MelanomaUveal NeoplasmsCell LineHistonesHumansMass SpectrometryMelanocytesPilot ProjectsUveal MelanomaHistones

Identifiers

PMID38349785
PMCPMC10868634
OpenAlexW4391774270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.